CH553780A - Verfahren zur herstellung von neuen 1,4-dihydropyridinderivaten. - Google Patents

Verfahren zur herstellung von neuen 1,4-dihydropyridinderivaten.

Info

Publication number
CH553780A
CH553780A CH101871A CH101871A CH553780A CH 553780 A CH553780 A CH 553780A CH 101871 A CH101871 A CH 101871A CH 101871 A CH101871 A CH 101871A CH 553780 A CH553780 A CH 553780A
Authority
CH
Switzerland
Prior art keywords
dihydropyride
derivatives
preparation
new
dihydropyride derivatives
Prior art date
Application number
CH101871A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CH553780A publication Critical patent/CH553780A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
CH101871A 1970-02-05 1971-01-22 Verfahren zur herstellung von neuen 1,4-dihydropyridinderivaten. CH553780A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2005116A DE2005116C3 (de) 1970-02-05 1970-02-05 Symmetrische 1,4-Dihydropyridin-3,5-dicarbonsäureester

Publications (1)

Publication Number Publication Date
CH553780A true CH553780A (de) 1974-09-13

Family

ID=5761434

Family Applications (1)

Application Number Title Priority Date Filing Date
CH101871A CH553780A (de) 1970-02-05 1971-01-22 Verfahren zur herstellung von neuen 1,4-dihydropyridinderivaten.

Country Status (17)

Country Link
US (1) US4048171A (de)
JP (1) JPS5550021B1 (de)
AT (1) AT302302B (de)
BE (1) BE762580A (de)
CA (1) CA944768A (de)
CH (1) CH553780A (de)
CS (1) CS161771B2 (de)
DE (1) DE2005116C3 (de)
DK (1) DK135282C (de)
ES (1) ES387973A1 (de)
FR (1) FR2150555B1 (de)
GB (2) GB1326491A (de)
IE (1) IE34896B1 (de)
IL (1) IL36018A0 (de)
NL (1) NL171580C (de)
YU (1) YU18471A (de)
ZA (1) ZA71438B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1430961A (en) * 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
GB1426499A (en) * 1973-10-02 1976-02-25 I Organischeskogo Sinteza Akad Pharmaceutical composition for treating liver diseases
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
DE2844130A1 (de) * 1977-10-14 1979-04-26 Labaz Neue dihydropyridine und deren verwendung
FR2405937A1 (fr) * 1977-10-14 1979-05-11 Labaz Nouveaux derives de dihydropyridine, leur procede de preparation et leur application
DE3021958A1 (de) * 1980-06-12 1981-12-24 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3247118A1 (de) * 1982-12-20 1984-06-20 Cassella Ag, 6000 Frankfurt Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4520131A (en) * 1983-03-03 1985-05-28 Usv Pharmaceutical Antihypertensive N-substituted 1,4-dihydropyridines
DE3410645A1 (de) * 1984-03-23 1985-09-26 Bayer Ag, 5090 Leverkusen L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4672068A (en) * 1984-05-04 1987-06-09 Fujirebio Kabushiki Kaisha Antihypertensive 1,4-dihydropyridines having a conjugated ester
US4683234A (en) * 1984-05-19 1987-07-28 Suntory Limited 2,6-Dimethyl-3N,5-disubstituted-4-(substituted phenyl)3,4-dihydropyrimidine compounds and a method for treating disorders of cardiocircular system
DE3432563A1 (de) * 1984-09-05 1986-03-13 Bayer Ag, 5090 Leverkusen Neue pyridylethyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimittel
US4728652A (en) * 1985-05-20 1988-03-01 E. R. Squibb & Sons, Inc. 2-substituted thio or oxy-4-aryl or heterocyclo-5-carboxy-1,4-dihydropyrimidines, composition containing them, and method of using them to reduce blood pressure
US5202330A (en) * 1985-06-03 1993-04-13 E. R. Squibb & Sons, Inc. 2-thio or oxo-4-aryl or heterocyclo-1,5(2H)-pyrimidinedicarboxylic acid diesters and 3-acyl-5-pyrimidinecarboxylic acids and esters
EP0220917B1 (de) * 1985-10-22 1991-01-30 Sanwa Kagaku Kenkyusho Co., Ltd. Pharmazeutische 1,4-Dihydropyridinderivate, ihre Salze und Herstellung
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
JPH0688973B2 (ja) * 1987-03-12 1994-11-09 京都薬品工業株式会社 1,4−ジヒドロピリジン誘導体
US4753946A (en) * 1987-04-08 1988-06-28 E. R. Squibb & Sons, Inc. Pyrimidinecarboxylic acid derivatives
US5216172A (en) * 1988-02-24 1993-06-01 Ajinomoto Co., Inc. 1,4-dihydropyridine-4-aryl-2,6-dimethyl-3,5-dicarboxylates useful as agents against drug resistant tumor cells
EP0330470A3 (de) * 1988-02-24 1992-01-02 Ajinomoto Co., Inc. Gegen Tumorzellen verwendbare 1,4-Dihydropyridin-Derivate
AU709190B2 (en) * 1996-01-29 1999-08-26 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Dihydropyridine-, pyridine-, benzopyran- one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists
AU2603197A (en) 1996-04-10 1997-10-29 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Use of an a1 adenosine receptor agonist to treat cerebral ischaemia
CA2336967C (en) 1998-07-10 2010-06-29 The United States Of America, Represented By The Secretary, Department Of Health And Human Services A3 adenosine receptor antagonists
AU3091301A (en) 2000-01-14 2001-07-24 Us Health Methanocarba cycloalkyl nucleoside analogues
US8518957B2 (en) 2009-12-02 2013-08-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing intraocular pressure

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325505A (en) * 1965-02-24 1967-06-13 Smith Kline French Lab 4-cycloalkyl(or cycloalkenyl)-dihydropyridines
US3511847A (en) * 1967-02-07 1970-05-12 Smithkline Corp 2,6-di-lower alkyl - 1,4-dihydro - 4-(2-trifluoromethylphenyl) - 3,5 - pyridinedicarboxylic acid esters
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
US3455939A (en) * 1967-06-07 1969-07-15 Smithkline Corp 4-(4-chloro-3-sulfamoylphenyl)-1,4-dihydropyridines
US3455945A (en) * 1967-06-07 1969-07-15 Smithkline Corp 4-(carboxy (and carbo-lower alkoxy)phenyl)-1,4-dihydropyridines
DE1813436C3 (de) * 1968-12-07 1979-01-11 Bayer Ag, 5090 Leverkusen N-Substituierte 2,6-Dimethyl-l,4dihydropyridine
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester
DE1963188A1 (de) * 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate
DE1963186C3 (de) * 1969-12-17 1979-02-15 Bayer Ag, 5090 Leverkusen Schwefelhaltige 1,4-Dihydropyridin-33-dicarbonsäureester

Also Published As

Publication number Publication date
DE2005116B2 (de) 1979-06-07
CA944768A (en) 1974-04-02
IE34896L (en) 1971-08-05
JPS5550021B1 (de) 1980-12-16
US4048171A (en) 1977-09-13
DE2005116A1 (de) 1971-09-02
ZA71438B (en) 1971-10-27
YU18471A (en) 1978-12-31
DK135282B (da) 1977-03-28
BE762580A (fr) 1971-08-05
GB1328479A (en) 1973-08-30
NL171580C (nl) 1983-04-18
CS161771B2 (de) 1975-06-10
FR2150555B1 (de) 1974-09-06
GB1326491A (en) 1973-08-15
IE34896B1 (en) 1975-09-17
IL36018A0 (en) 1971-03-24
NL171580B (nl) 1982-11-16
FR2150555A1 (de) 1973-04-13
AT302302B (de) 1972-10-10
ES387973A1 (es) 1974-01-16
NL7101234A (de) 1971-08-09
DE2005116C3 (de) 1980-02-14
DK135282C (da) 1977-08-15

Similar Documents

Publication Publication Date Title
CH553780A (de) Verfahren zur herstellung von neuen 1,4-dihydropyridinderivaten.
AT306720B (de) Verfahren zur Herstellung von neuen 1,4-Dihydropyridinderivaten
AT303040B (de) Verfahren zur Herstellung von neuen Azidophenyl-1,4-dihydroppyridinen
AT315856B (de) Verfahren zur herstellung von neuen 4-hydroxy-6-aryl-bzw.6-heteroarylpyrimidinen
AT331258B (de) Verfahren zur herstellung von neuen 1,2,3-oxathiazin-4-onen
CH551979A (de) Verfahren zur herstellung von 1,2-dihydropyrimidinen.
AT319948B (de) Verfahren zur Herstellung von neuen 2,4-Diamino-5-benzylpyrimidinen
AT310953B (de) Verfahren zur Herstellung von neuen 8,9-Didehydro-10-alkoxyergolenderivaten
AT312606B (de) Verfahren zur Herstellung von neuen 2,2-Diaryl-4-piperidinbutyramiden
AT299968B (de) Verfahren zur Herstellung von neuen 5-Imino-1,2,4-triazin-Derivaten
CH556352A (de) Verfahren zur herstellung von 2-acylamino-1,3,4-thiadiazol-(thi)onen-(5).
CH550786A (de) Verfahren zur herstellung von 2,9-dioxatricyclo (4,3,1,0 3,7) decanonen.
CH549034A (de) Verfahren zur herstellung von neuen benzodiazepin-derivaten.
CH555332A (de) Verfahren zur herstellung von neuen 1,3,3-trisubstituierten 3-azolylpropinen.
CH546730A (de) Verfahren zur herstellung von n,n'-bis-trifluormethyl-tetrafluoraethylendiamin.
CH549035A (de) Verfahren zur herstellung von neuen benzodiazepin-derivaten.
CH556852A (de) Verfahren zur herstellung von neuen 1,4-benzodiazepinen.
AT306259B (de) Verfahren zur Herstellung von neuen 3-Oxo-11β,18-epoxy-17α-R-17β-hydroxyöstra-4,9-dienen
CH557825A (de) Verfahren zur herstellung von 2,3-dihydrobenzodiazepinen.
AT300792B (de) Verfahren zur Herstellung von neuen modifizierten N,N'substituierten 2,4,5-Triketoimidazolidinen
AT281816B (de) Verfahren zur Herstellung von neuen 1,2-Benzixothiazol-Derivate
CH518941A (de) Verfahren zur Herstellung von neuen 3,5-Dioxopyrazolidinderivaten
CH547796A (de) Verfahren zur herstellung von 1,3-dioxolanen und -dioxanen.
AT299946B (de) Verfahren zur Herstellung von neuen 1,3-Benzodioxol-2-thionen
AT306252B (de) Verfahren zur Herstellung von neuen 2,3-Alkylidenrhamnopyranosiden

Legal Events

Date Code Title Description
PL Patent ceased